NRC Health vs Phreesia, Inc. — Valuation Comparison 2026
Access all valuation models for NRC vs PHR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →PHR scores higher with a 7.6/10 quality rating vs NRC's 7.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing NRC Health (NRC) and Phreesia, Inc. (PHR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
NRC currently trades at $19.66 with a QOC of 7.2/10, while PHR trades at $9.45 with a QOC of 7.6/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).